• Applied Biological Chemistry
• /
• 제29권3호
• /
• pp.304-310
• /
• 1986

CL 배지에서 자란 A. calcoaceticus C10은 glucose dehydrogenase(GDH)와 cyclohexanol dehydrogenase(CDH)를 모두 생산하였다. A. calcoaceticus C10에 의한 사이클로헥사놀의 산화가 비특이적인 GDH에 의한 것인지를 알아보기 위하여 GDH와 CDH의 차이를 조사한 결과 GDH는 $NAD^+$와 $NADP^+$를 모두 조효소로 이 용하였으나 CDH는 $NAD^+$만을 조효소로 이용하였으며 $NADP^+$를 이용하지 못하였다. GDH는 LB 배지와 0.2%의 포도당 또는 사이클로헥사놀을 첨가한 LB 배지 및 CL 배지에서 모두 생산되었으나 CDH는 사이클로헥사놀을 첨가한 배지에서만 생산되었으며 7.5% polyacrylamide 젤 전기영동 결과 GDH와 CDH는 서로 다른 활성 밴드를 나타내었다. 이로써 GDH와 CDH는 서로 다른 것이며 사이클로헥사놀의 산화는 비특이적인 GDH에 의한 것이 아님을 확인하였다. LB 배지에서 A. calcoaceticus C10을 4시간 배양 후 사이클로헥사놀을 첨가할 경우 배양 24시간에 LB 배지에서보다 약 8배의 CDH 활성을 나타내었으며 생육도는 약 2배의 증가현상을 나타내었다. CDH는 사이클로헥사놀, 사이클로헥사논 cyclohexan-1,2-diol 및 cyclohexene oxide에 의해 유도되었으나 ${\varepsilon}-caprolactone$과 adipate에 의해서는 유도되지 않았다.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제22권4호
• /
• pp.287-293
• /
• 2011

Objectives : The region of chromosome 5p14 is known to be associated with autism spectrum disorder (ASD). The cadherin9 (CDH9) and cadherin10 (CDH10) genes are located in the region of chromosome 5p14 and reported to be associated with ASD in the Caucasian population. We performed an association study to identify if single nucleotide polymorphisms (SNPs) located on the CDH9 and CDH10 genes are associated in the Korean population. Methods : Genomic DNA was extracted from the blood of 214 patients with ASD and 258 controls. SNPs selected from two genes were genotyped using an Illumina Golden-Gate Genotyping assay with VeraCode technology. Statistical analysis was performed using SAS and Plink software. Results : All controls and ASD patients were in Hardy-Weinberg equilibrium. In the results of logistic regression analyses for the genotype model and the chi-square test for the allele model, we found that SNPs on the CDH9 and CDH10 genes were not associated with ASD. Conclusion : Our data suggests that the CDH9 and CDH10 genes are not associated with ASD in the Korean population.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권3호
• /
• pp.1139-1143
• /
• 2015

In order to explore the association between cadherin 13 (CDH13) gene promoter methylation and lung carcinoma (LC) risk, we carried out a meta-analysis with searching of PubMed, Web of Science. Ultimately, 17 articles were identified and analysised by STATA 12.0 software. Overall, we found a significant relationship between CDH13 promoter methylation and LC risk (odds ratio=6.98, 95% confidence interval: 4.21-11.56, p<0.001). Subgroup analyses further revealed that LC risk was increased for individuals carrying the methylated CDH13 compared with those with unmethylated CDH13. Hence, our study identified a strong association between CDH13 gene promoter methylation and LC and highlighted a promising potential for CDH13 methylation in LC risk prediction.

• Journal of the Korean Association of Oral and Maxillofacial Surgeons
• /
• 제34권5호
• /
• pp.525-531
• /
• 2008

CDH-13(T-cadherin), which is one of a kind among the 20 cadherins, can be found mainly in wall of aorta, neuron, spleen, blood vessel etc. It is also called H-cadherin. This structural difference can explain that CDH-13 is thought to play a key role in maintaining mutual relation between extra and intra-cellular environment rather than in cell adhesion. The main function of CDH-13 is to participate in blood vessel function. Additionally, it is known to regulate cell growth and cell contact inhibition. When cells are proliferating, cell surface perceives other cells so that substance such as CDH-13 can inhibit their growth or proliferation resulting in homeostasis without endless proliferation or invasion of connective tissue boundaries. However, tumor cell itself appears to be different from normal cells' growth, invasion or transmission. Therefore, it can be diagnosed that these characteristics are closely related to expression of CDH-13 in tumor cells. This study is to investigate expression of CDH-13 in SCC and its correlation with promoter methylation. 20 of tissue species for the study are excised and gathered from 20 patients who are diagnosed as SCC in department of OMS, dental hospital, dankook university. To find development of CDH-13 in each tissue samples, immunohistochemical staining, RT-PCR gene analysis and methylation specific PCR are processed. The results are as follows. 1.Immunohistochemical staining: In normal oral squamous epithelial tissue, strong expression of CDH-13 was found in cell plasma membrane of basal cell layer. On the other hand, in case of low-differentiated oral SCC, development of CDH-13 was hardly seen. 2.The development of CDH-13 gene: In 9 of samples, expression of CDH-13 gene could be seen and 2 of them showed low expression compared to the others. And rest of the 11 samples showed no expression of CDH-13 gene. 3.Methylation of CDH-13 gene: Among 9 samples which expressed CDH-13 gene, 7 of them showed unmethylation. In addition, among 11 samples without CDH-13 gene expression, 10 showed methylation. According to the results stated above, promoter methylation were found in 13 samples(65%) among 20 of oral SCC samples. In low-differentiated SCC, suppression of gene expression could be seen accompanying promoter methylation. These phenomenon of gene expression was proved by immunohistochemical investigation. Finally, for development of oral SCC, conclusions can be made that suppression of CDH-13 played a main role and suppression of gene expression was originated from promoter methylation. Considering this, it is expected that suppression of CDH-13 from promoter methylation to be utilized as a good diagnostic marker of oral SCC.

• Journal of Microbiology and Biotechnology
• /
• 제34권2호
• /
• pp.457-466
• /
• 2024

Cellobiose dehydrogenases (CDHs) are a group of enzymes belonging to the hemoflavoenzyme group, which are mostly found in fungi. They play an important role in the production of acid sugar. In this research, CDH annotated from the actinobacterium Cellulomonas palmilytica EW123 (CpCDH) was cloned and characterized. The CpCDH exhibited a domain architecture resembling class-I CDH found in Basidiomycota. The cytochrome c and flavin-containing dehydrogenase domains in CpCDH showed an extra-long evolutionary distance compared to fungal CDH. The amino acid sequence of CpCDH revealed conservative catalytic amino acids and a distinct flavin adenine dinucleotide region specific to CDH, setting it apart from closely related sequences. The physicochemical properties of CpCDH displayed optimal pH conditions similar to those of CDHs but differed in terms of optimal temperature. The CpCDH displayed excellent enzymatic activity at low temperatures (below 30℃), unlike other CDHs. Moreover, CpCDH showed the highest substrate specificity for disaccharides such as cellobiose and lactose, which contain a glucose molecule at the non-reducing end. The catalytic efficiency of CpCDH for cellobiose and lactose were 2.05 × 10⁵ and 9.06 × 10⁴ (M^-1 s^-1), respectively. The result from the Fourier-transform infrared spectroscopy (FT-IR) spectra confirmed the presence of cellobionic and lactobionic acids as the oxidative products of CpCDH. This study establishes CpCDH as a novel and attractive bacterial CDH, representing the first report of its kind in the Cellulomonas genus.

• Korean Chemical Engineering Research
• /
• 제49권1호
• /
• pp.101-104
• /
• 2011

Hemoflavoenzyme으로서 cellobiose dehydrogenase(CDH)는 셀룰로오스를 분해하는 과정에서 세포 외부로 분비되는 효소로서 amorphous cellulose와 강하게 결합하여 셀룰라아제(cellulase)에 의해 microcrystalline cellulose의 가수분해를 증가시킨다. 따라서 CDH는 바이오 에탄올 생산의 당화공정에서 중요한 역할을 할 것으로 예상된다. 여러 백색부후균으로부터 CDH 생산이 높은 Phanerochaete chrysosporium ATCC 32629 균주를 선정하였으며, 균주로부터 생산된 CDH 효소활성의 최적 온도와 pH는 각각 ${55^{\circ}C}$와 4이었다. CDH 활성을 증가시키기 위하여 P. chrysosporium ATCC 32629 균주를 돌연변이시켰다. 돌연변이는 새로운 시도로써 국부적으로 큰 에너지를 줄 수 있는 특징을 가진 양성자 빔을 이용하였다. 양성자 빔 조사 후 사멸율이 약 99.9%인 1.2 kGy에서 CDH 활성이 증가된 변이주를 얻었다. 선별된 변이주와 모균주를 액체배양했을 때 변이주가 모균주보다 CDH와 $\beta$-glucosidase 활성이 각각 약 1.4배와 20배 증가하였다. 따라서, CDH 뿐만 아니라 $\beta$-glucosidase 활성이 높은 P. chrysosporium 변이주를 확보하였다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권12호
• /
• pp.4925-4928
• /
• 2014

Background: This study aimed to evaluate the methylation of RASSF1A and CDH13 gene promoter regions as a marker for monitoring chemotherapeutic efficacy with personalized medicine for patients with NSCLC, in the hope of providing a new direction for NSCLC individualized chemotherapy. Materials and Methods: 42 NSCLC patients and 40 healthy controls were included. Patient blood samples were collected in the whole process of chemotherapy. Methylation of RASSF1A and CDH13 gene promoter regions was detected by the methylation specific polymerase chain reaction (MSP). Results: The rate of RASSF1A and CDH13 gene methylation in 42 cases of NSCLC patients was significantly higher than in 40 healthy controls (52.4% to 0.0%, 54.8% to 0.0%, p<0.05). After the chemotherapy, the hyper-methylation of RASSF1A and CDH13 genes in PR group and SD group decreased significantly (p<0.05), and was significantly different from that in PD group (p<0.05), but not as compared with healthy controls (P>0.05). With chemotherapy, RASSF1A and CDH13 promoter region methylation rate in 42 cases of patients showed a declining trend. Conclusions: The methylation level of RASSF1A and CDH13 gene promoter region can reflect drug sensitivity of tumors to individualized treatment.

• The Korean Journal of Pain
• /
• 제37권3호
• /
• pp.247-255
• /
• 2024

Background: Little is known about the frequency and impact of the persistent headache and about the incidence of chronic daily headache (CDH) after coronavirus disease 2019 (COVID-19). The aim of this prospective cohort study was to assess the incidence, risk factors, characteristics, and impact of CDH in patients with COVID-19. Methods: In the first stage, 288 patients were interviewed by telephone after the acute phase of COVID-19. Subsequently, 199 patients who presented headache were reinterviewed at least one year after COVID-19. Headaches that persisted beyond the acute phase of COVID-19 for three or more months and presented frequency ≥ 45 days over the first three months were considered to be CDH. Results: One hundred and twenty-three patients were included, 56% were females; median age: 50 years (25th and 75th percentile: 41;58). The headache persisted beyond the acute phase of COVID-19 in 52%, and 20.3% had CDH (95% confidence interval: 13.6-28.2). Individuals who previously had headaches and who had headaches of greater intensity during the acute phase were at higher risk of developing CDH. The group with CDH included more females, greater impact of headache, more persistence of headache beyond the 120th day of COVID-19 and less throbbing headache than did the other individuals whose headache persisted. Conclusions: Patients who had COVID-19 had a high incidence of CDH. Previous headache and greater intensity of headache were associated with higher risk of CDH.

• BMB Reports
• /
• 제44권11호
• /
• pp.725-729
• /
• 2011

We report a novel mechanism of a CDH1 splicing mutation in a patient with signet ring cell carcinoma of the stomach. A 27-year-old man complaining of aggravated dyspepsia was diagnosed with signet ring cell carcinoma. Both his father and uncle had died of stomach cancer at a young age. DNA sequencing analysis of the CDH1 gene revealed a splice site mutation (c.833-2A>G). By RNA/cDNA sequencing analysis, CDH1 c.833-2A>G generated a new acceptor site within intron 6, causing the insertion of a 79-bp intronic sequence between exon 6 and 7 (r.833-79_833-1ins), and resulting in a frame shift. E-cadherin immunohistochemical staining revealed a loss of CDH1 expression. This study reveals the disease-causing mechanism of this splicing mutation, and emphasizes the need for functional studies using RNA samples for the accurate interpretation of detected splicing variant. This is the first reported case of a CDH1 mutation in a Korean patient.

• 정보보호학회논문지
• /
• 제19권6호
• /
• pp.195-199
• /
• 2009

이 논문에서는 CDH가정에 안전성을 기초로 하는 공격자가 참여하는 새로운 문제를 정의하고 이의 안전성을 증명한다. 이 새로운 문제는 암호 프로토콜의 설계에서 프리미티브로 이용될 수 있다. 이 논문에서는 이 문제의 응용 예로 새로운 identification 기법을 보인다. 또한, 이 문제의 판별 버전(decisional version)에 대해서도 살펴본다.